Visalytics
Visalytics
approved EB-2 (NIW)

Staff Scientist

Immunotherapy · China · 2025-04-03

Processing Time
354 days
Decision Date
2025-04-03
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses pressing healthcare priorities and therapeutic innovation for cancer and autoimmune diseases.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 14 publications, 411 citations, and federal grant funding demonstrates her capability to lead this research.

3 Balance of Interests Met

The practical impact of her work on accessible treatment pathways makes it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 14 peer-reviewed journal articles (including 7 as first or co-first author) and 411 total citations. Additionally, she completed over 20 peer reviews and received funding from the National Cancer Institute (NCI) and the National Heart, Lung, and Blood Institute (NHLBI), satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Reference Letters Dependent
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Research Scientist

Biotechnology · Slovenia

WeGreened EB-2 (NIW) approved
New York 64 days 2025-02-24
The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
New Jersey 180 days 2025-09-03
The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-03.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 354 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist